10 Key Players in the Global Insulin Pen Market You Should Know

10 Key Players in the Global Insulin Pen Market You Should Know


Mar 25, 2024

Blog Med Devices & Surgical 10 Key Players in the Global Insulin Pen Market You Should Know

Insulin pens are growing in popularity with the passage of time as the world has been witnessing an exponential surge in diabetes. From their inception as relatively basic delivery devices, insulin pens have undergone a substantial transformation, becoming highly advanced and user-friendly tools. These pens provide a practical, discreet, and accurate method of delivering insulin, allowing people with diabetes to administer exact amounts effortlessly and enabling them to live more flexible and balanced lives.

As the demand for more convenient and precise methods of insulin delivery continues to rise, the global insulin pen market is witnessing significant growth. According to BCC Research, the market is projected to experience substantial expansion, with a forecasted increase from $9.9 billion in 2022 to $14.1 billion in 2028. This significant growth is expected at a compound annual growth rate (CAGR) of 6.1% during the period from 2023 to 2028.

In this listicle, we'll introduce you to 10 key players shaping the landscape of the global insulin pen market. These companies play a pivotal role in developing cutting-edge technologies and solutions to enhance the lives of individuals managing diabetes.



Global Insulin Pen Market

The global Insulin Pens market is projected to grow from $9.9 billion in 2022 to $14.1 billion in 2028 at a compound annual growth rate (CAGR) of 6.1 % during the forecast period.

Key Companies in the Insulin Pen Industry

Novo Nordisk A/S (Established: 1923)

A Denmark-based multinational pharmaceutical company with over 95 years of expertise in diabetes care, stands as a global healthcare leader. Renowned for its innovative solutions in the insulin pen market, including NovoPen Echo, NovoPen 5, NovoPen 4, NovoPen Junior, and NovoPen 3, the company exemplifies a commitment to effective and user-friendly diabetes management. Beyond diabetes, Novo Nordisk leverages its heritage to address obesity, haemophilia, growth disorders, and other chronic diseases, showcasing a steadfast dedication to advancing healthcare and improving lives globally.

Eli Lilly and Company (Established: 1876)

Eli Lilly, a U.S.-based global pharmaceutical company, is renowned for its development and marketing of innovative medicines across various therapeutic areas, with a significant focus on diabetes care. The company, known for its pioneering contributions, offers insulin pens such as HumaPen and KwikPen. Eli Lilly holds the distinction of introducing the world’s first commercial insulin in the 1920s and continues to be a leading producer of products for individuals with diabetes.

Sanofi (Established: 1853)

A France-based multinational pharmaceutical company engaged in the research, development, manufacturing, and marketing of pharmaceutical products. Sanofi is a major player in the insulin pen market, offering a range of insulin delivery devices, including SoloStar, ClikSTAR, JuniorSTAR, AllStar, and OptiClik. The company launched AllStar™, the first Indian-manufactured, reusable insulin pen, developed especially for patients in emerging markets.

Biocon Limited (Established: 1978)

An Indian biopharmaceutical company, is engaged in the research, development, and commercialization of innovative therapies. The company manufactures insulin pens as part of its diabetes care portfolio, including products like Insupen and Basalog One. Having been involved in insulin development since 2000, Biocon aims to provide affordable access to insulin and has successfully delivered over 2 billion doses of human insulin worldwide.

Becton, Dickinson and Company (Established: 1897)

A leading U.S.-based medical technology company, specializes in manufacturing insulin pen needles. They offer a wide range of medication delivery and management solutions, including insulin pens such as BD Pen Needles, Insulin Syringes, and diabetic pens like BD Vystra. BD prioritizes comfort and precision for a smoother injection experience.

Ypsomed AG (Established: 2003)

A Swiss-based company specializing in the development and manufacturing of injection and infusion systems for self-medication, Ypsomed is a key player in the insulin pen market. The company provides user-friendly and innovative pen devices such as YpsoPen, UnoPen, and YpsoDose. Ypsomed collaborates with pharmaceutical companies to develop customized insulin pens.

Medtronic plc (Established: 1949)

An Irish medical technology company, is a global leader in the field, providing a comprehensive solution for diabetes management. The company offers the MiniMed Paradigm pump and pens, which seamlessly integrate with continuous glucose monitoring systems. This integration provides patients with a comprehensive and integrated solution for effectively managing their diabetes.

Gan & Lee (Established: 1988)

An Indian pharmaceutical company, is a leading provider of affordable and reliable insulin pens, catering specifically to the needs of the Indian market. The company has developed the first Chinese domestic biosynthetic human insulin and has a series of insulin products approved in China. Ganlee offers a range of user-friendly pens with long-lasting cartridges and competitive pricing, ensuring accessibility for patients in India.

AstraZeneca (Established: 1999)

A UK-based multinational pharmaceutical company, AstraZeneca, specializes in the research, development, and marketing of pharmaceutical products, with a notable focus on diabetes care. In the insulin pen market, AstraZeneca offers the BYDUREON BCise, an extended-release exenatide pen designed to enhance glycemic control in adults with type 2 diabetes. Their commitment to advancing diabetes care highlights their influential role in providing effective and convenient insulin delivery options globally.

Wockhardt Ltd. (Established: 1960)

An Indian pharmaceutical and biotechnology company, Wockhardt specializes in the research, development, manufacturing, and marketing of pharmaceutical and biopharmaceutical formulations. The company produces insulin pens, including the Wosulin Pen, and holds 16 patents for this easy-to-use device designed for administering insulin.

In wrapping up our exploration of top players in the global insulin pen industry, it's clear that innovation and user-centric solutions lead the way. From Novo Nordisk's heritage to Ganlee's affordability commitment, each company shapes diabetes management. Stay informed about advancements and trends in this dynamic industry. This listicle is your starting point for effective diabetes care, whether exploring tech or user-friendly solutions. These companies pave the way for a brighter future in diabetes management. Thank you for exploring the dynamic world of insulin pens with us!

Learn More and Take Action: 

Consider becoming a member of the BCC Research library and gain access to our full catalog of market research reports in your industry. Not seeing what you are looking for? We offer custom solutions too, including our new product line: Custom Intelligence Services.

Contact us today to find out more.

    Stay ahead of industry trends, build your market research strategy and more.

    Karishma Arora

    Written By Karishma Arora

    Karishma Arora is an Assistant Team Lead in Marketing Operations at BCC Research, with a master's degree in commerce. She is a passionate marketer with a knack for creativity and data-driven strategies.

    Guiding smart decisions every step of the way

    Guiding smart decisions every step of the way

    We are your trusted research partner, providing actionable insights and custom consulting across life sciences, advanced materials, and technology. Allow BCC Research to nurture your smartest business decisions today, tomorrow, and beyond.

    Contact Us